Fortuitous Discovery of A Primary Ovarian ChoriocarcinomaDuringa Caesarean Section: About a Case
Journal Title: Scholars Journal of Medical Case Reports - Year 2017, Vol 5, Issue 8
Abstract
Pure ovarian choriocarcinomas are extremely rare and aggressive tumors that may be gestational or non-gestational in origin. Due the rarity of tumor, there is aack of information on the clinicopathologic features, diagnosis, and treatment. We report a case of pure metastatic ovarian choriocarcinoma, to liver and lung, probably of gestational origin, which was accidentally discovered during a caesarean section, treated by surgery and whose chemotherapy could not be conducted on time.
Authors and Affiliations
Tapa E, Rahali M, Lebbar K, Fichtali K, Benhessou M, Bouhya S
Parapharyngeal Schwannoma- A Rarity: Case Report with Review of Literature
Schwannomas are solitary, benign, well-circumscribed, encapsulated, slow-growing tumors originating from Schwann cells of the peripheral nerve sheath. Approximately 30-45% of cases occur in the head and neck region, of w...
A Case of Severe Acute Kidney Injury Induced by Near-Drowning
A 23-year-old man began drowning when he suffered a leg spasm while snorkeling in the ocean. After being rescued, he showed consciousness disturbance and a pale face. On arrival, chest roentgen showed decreased radioluce...
Chest Wall Rhabdomyosarcoma in Newborn- The Rarest of Rare Site in a Newborn: A Case Report
Abstract: Soft tissue tumours are rare in childhood with most common being benign low flow vascular malformation (Heamangiomas). Neonatal soft tissue malignancy is rare. Chest wall as the primary site has been rarely rep...
A Challenging Diagnosis of Brain Tuberculoma in a Healthy Girl
Abstract:A 16-year-old healthy girl presented with headache, nausea and vomiting with double vision for three weeks. On ocular examination, there was right esotropia with bilateral papilloedema. Magnetic resonance imagin...
Challenges in Managing Locally Aggressive Pelvic Chondrosarcoma: A Case Report
Chondrosarcoma (CS) is a primary bone malignancy which differentiated from the cartilage tissue. It accounts for approximately 20% of malignant bone tumours. It ranks the third most common primary bone malignancy after o...